More importantly, we found that chronic blockade of TLR4 lowers MAP in diabetic animals (mmHg: 79 ± 1.87 vs. 104.3 ± 2.46; treated vs. non-treated), suggesting that this receptor might contribute to prolonged type 1 diabetes-induced hypertension. Here, TLR4 is linked to hypertensive disorder.